These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8730713)

  • 1. Burst stimulation of the medial forebrain bundle selectively increase Fos-like immunoreactivity in the limbic forebrain of the rat.
    Chergui K; Nomikos GG; Mathé JM; Gonon F; Svensson TH
    Neuroscience; 1996 May; 72(1):141-56. PubMed ID: 8730713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain.
    Guo N; Klitenick MA; Tham CS; Fibiger HC
    Neuroscience; 1995 Apr; 65(3):747-56. PubMed ID: 7609873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle.
    Chergui K; Svenningsson P; Nomikos GG; Gonon F; Fredholm BB; Svennson TH
    Eur J Neurosci; 1997 Nov; 9(11):2370-82. PubMed ID: 9464931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y.
    Robertson GS; Staines WA
    Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain.
    Wan W; Ennulat DJ; Cohen BM
    Brain Res; 1995 Aug; 688(1-2):95-104. PubMed ID: 8542328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rewarding brain stimulation induces only sparse Fos-like immunoreactivity in dopaminergic neurons.
    Hunt GE; McGregor IS
    Neuroscience; 1998 Mar; 83(2):501-15. PubMed ID: 9460758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
    Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
    Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of YM-43611, a novel dopamine D2-like receptor antagonist, on immediate early gene expression in the rat forebrain.
    Kurokawa K; Narita M; Koshiya K; Hidaka K; Ohmori J; Satoh K
    Neuropsychopharmacology; 1997 Jul; 17(1):27-33. PubMed ID: 9194047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields.
    Dilts RP; Helton TE; McGinty JF
    Synapse; 1993 Mar; 13(3):251-63. PubMed ID: 8497810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dopamine antagonist blocks vaginocervical stimulation-induced neuronal responses in the rat forebrain.
    Quysner A; Blaustein JD
    Brain Res; 2001 Dec; 921(1-2):173-82. PubMed ID: 11720724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in desensitization of c-Fos expression following repeated self-stimulation of the medial forebrain bundle in the rat.
    Nakahara D; Ishida Y; Nakamura M; Kuwahara I; Todaka K; Nishimori T
    Neuroscience; 1999 Mar; 90(3):1013-20. PubMed ID: 10218800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
    Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
    Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
    Robertson GS; Fibiger HC
    Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas.
    Pinna A; Wardas J; Cristalli G; Morelli M
    Brain Res; 1997 Jun; 759(1):41-9. PubMed ID: 9219861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine.
    Watanabe K; Hashimoto K; Nishimura T; Tsunashima K; Minabe Y
    Brain Res; 1998 Jun; 797(1):135-42. PubMed ID: 9630573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perospirone, a novel 5-HT2 and D2 receptor antagonist, on Fos protein expression in the rat forebrain.
    Ishibashi T; Tagashira R; Nakamura M; Noguchi H; Ohno Y
    Pharmacol Biochem Behav; 1999 Aug; 63(4):535-41. PubMed ID: 10462181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor induces Fos-like immunoreactivity within identified cholinergic neurons in the adult rat basal forebrain.
    Gibbs RB; Martynowski C
    Brain Res; 1997 Apr; 753(1):141-51. PubMed ID: 9125441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress induces Fos expression in neurons of the thalamic paraventricular nucleus that innervate limbic forebrain sites.
    Bubser M; Deutch AY
    Synapse; 1999 Apr; 32(1):13-22. PubMed ID: 10188633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-OH-DPAT differentially reverses clozapine- and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain.
    Vahid-Ansari F; Robertson GS
    Eur J Neurosci; 1996 Dec; 8(12):2605-11. PubMed ID: 8996810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.